Author:
Takayama K,Ito Y,Kaneko H,Kataoka K,Sugita T,Maruko R,Hattori K,Ra E,Haga F,Terasaki H
Publisher
Springer Science and Business Media LLC
Subject
General Arts and Humanities,Ophthalmology,Sensory Systems
Reference24 articles.
1. Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC, Spaide RF et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999; 117: 1503–1510.
2. Sho K, Takahashi K, Yamada H, Wada M, Nagai Y, Otsuji T et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003; 121: 1392–1396.
3. Ciardella AP, Donsoff IM, Huang SJ, Costa DL, Yannuzzi LA . Polypoidal choroidal vasculopathy. Surv Ophthalmol 2004; 49: 25–37.
4. Schachat AP, Thompson JT . Optical coherence tomography, fluorescein angiography, and the management of neovascular age-related macular degeneration. Ophthalmology 2015; 122: 222–223.
5. Kokame GT . Prospective evaluation of subretinal vessel location in polypoidal choroidal vasculopathy (PCV) and response of hemorrhagic and exudative PCV to high-dose antiangiogenic therapy (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2014; 112: 74–93.